Skip to main content
. 2022 Aug 1;12(8):e055324. doi: 10.1136/bmjopen-2021-055324

Table 1.

Exclusion criteria per patient group

Breast cancer Stoke Advanced kidney disease
  • Male patients

  • Predisposing genetic mutations related to breast cancer

  • Non-invasive breast cancer

  • History of neoadjuvant systemic therapy or treatment for a recurrence or second primary tumour

  • Palliative treatment

  • Reduced consciousness

  • On kidney replacement therapy or conservative care management